A Study to Assess Effectiveness of Venclexta (Venetoclax) in Patients With Relapse or Refractory Chronic Lymphocytic Leukemia in Routine Clinical Practice in Russian Federation

Study Identifier
P19-569
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Blood Cancer - Chronic Lymphocytic Leukemia (CLL)
  • Cancer - Other
  • Study Drug
  • Venetoclax
  • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years

    Protocol Summary

    This study seeks to assess the effectiveness and safety of venetoclax in patients with relapsed and refractory chronic lymphocytic leukemia (CLL) in a real-world setting across clinical practice in the Russian Federation.

    Study Locations

    Location
    Status
    Location
    Oncology Dispensary #2 /ID# 215831
    Sochi, Krasnodarskiy Kray, Russian Federation, 354057
    Status
    Not applicable
    Location
    Moscow State budget healthcare /ID# 212875
    Moscow, Moscow, Russian Federation, 125284
    Status
    Not applicable
    Location
    Moscow Regional Research and Clinical Institute n.a. Vladimirskiy (MONIKI) /ID# 215830
    Moscow, Moscow Oblast, Russian Federation, 129110
    Status
    Not applicable
    Location
    Academician I.P. Pavlov First St. Petersburg State Medical University /ID# 212368
    Saint Petersburg, Sankt-Peterburg, Russian Federation, 197101
    Status
    Not applicable
    Location
    Central City Hospital #7 /ID# 212373
    Yekaterinburg, Sverdlovsk Oblast, Russian Federation, 620137
    Status
    Not applicable
    Location
    Regional Children's Clinical Hospital of Volgograd /ID# 212366
    Volgograd, Volgograd Oblast, Russian Federation, 400138
    Status
    Not applicable
    Showing {first} - {last} of {total} Results